Activities / IVAA and CAM / CAM Survey 2009
Recognition of Anthroposophic Medicine

Recognition of Anthroposophic Medicine (AM)
 
Recognition of AM is subject to extreme variations between EU Member states. The level of recognition extends from statutory integration as specific therapeutic system within national law (Germany and Switzerland) to special exemption where AM may only be practised within the context of a particular clinic (Vidarkliniken, Sweden). With the exception of Germany, where AM is defined as “special therapeutic system” [Besondere Therapierichtung] in the Code of Social Law (Sozialgesetzbuch 5), and Switzerland, where AM is defined as part of CAM under constitutional law, legal recognition is restricted to pharmaceutical regulations in some of the member states (see below).
 

National laws regulating Anthroposophic Medicine as a distinct medical therapy

Only in Germany is AM recognised as therapeutic system under statutory regulations.

In Denmark, Finland, Sweden and the UK, anthroposophic medicinal products (AMP) are mentioned to varying degrees in national pharmaceutical laws in particular in connection with simplified registration procedures for homeopathic medicinal products.

In Sweden the anthroposophic clinic (Vidarkliniken) has a permit from the minister of social affairs, but doctors are only allowed to practise anthroposophic medicine if they do so at, or in connection with the Vidarkliniken


Regulation of the profession of anthroposophic doctors by the medical association/council/chamber

As mentioned above, in some countries where the government delegates the tasks of authorisation, registration and supervision of practitioners to national medical associations, statutory regulation of anthroposophic doctors requires an “additional qualification” issued by the medical assocation/council/chamber (Austria, Bulgaria, Germany, Latvia and Switzerland). In Italy AM is recognised through statutory regulation by the local medical associations/chambers/councils in Bologna, Terni and Palermo.
  
 
Diplomas for anthroposophic doctors
  
Diplomas for anthroposophic doctors are issued after satisfactory fulfilment of the required criteria for training and qualification in AM. In all member states with training institutions the curricula are established under the auspices and supervision of the national association of anthroposophic doctors. In most EU member states, diplomas for anthroposophic doctors are issued by the national associations of anthroposophic doctors.
In Austria and Switzerland such diplomas are issued and recognised by the national medical associations/chambers/councils.
 
In Bulgaria, Germany, Italy, Latvia and Spain the diplomas are issued by the national association of anthroposophic doctors and recognised by the national medical associations/chambers/councils.
In Belgium, Finland, France, Hungary, Netherlands, Poland, Romania, Sweden and the UK diplomas in Anthroposophic Medicine are not recognised.
 
In member states without national training facilities, doctors can apply for international certification which is issued by the Medical Section at the Goetheanum in Dornach. The criteria for this international certification have been worked out and agreed by the International Federation of Anthroposophic Medical Associations. Doctors can also apply for the international diploma in member states where national training facilities exist. However, this is possible only by authorisation of the national association of anthroposophic doctors.
 
 
Anthroposophic Medicine at universities
 
University professorial chairs for AM are established at universities in Germany (Witten-Herdecke and Alfter), and within the context of CAM in Italy (Firenze and Bologna) and in Switzerland (Bern).
Introductory courses in AM are offered as an optional part of the medical undergraduate curriculum in Austria, Germany, the Netherlands, Spain, Sweden and Switzerland. The courses are usually integrated into courses on CAM in general.

Postgraduate medical training courses in AM are provided at private teaching centres in Austria, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Poland, Romania, Spain, Switzerland and the UK, usually under the auspices of the national associations of anthroposophic doctors. 

  
Therapists in Anthroposophic Medicine
 
Anthroposophic therapies such as eurythmy therapy (a special movement therapy), artistic therapy (painting, modelling, singing, music), therapeutic speech, anthroposophic physiotherapy and rhythmical massage, and anthroposophic nursing etc. are an essential part of Anthroposophic Medicine. Every therapist is well trained according to curricula specific to the respective therapy. A special feature of AM is that these therapists provide their skills/services in accordance with a medical prescription from a doctor, as part of the integrated anthroposophic approach to medicine.
  
 
Continuing Medical Education (CME)
 
Obligatory Continuing Medical Education (CME) in conventional medicine is required in most member states. It is under government control in Belgium, the Czech Republic, Hungary, Italy, and Lithuania, or controlled by national medical associations/chambers/councils in the Czech Republic, Estonia, France, Germany, Latvia, Netherlands, Poland, Romania, Spain, Sweden, Switzerland and the UK . The required number of hours per annum is: 80 (Switzerland), 50 (Germany, Hungary, Romania and the UK), 40-60 (Netherlands).
 
In addition, the national associations of anthroposophic doctors in Germany, Hungary, Netherlands, Romania and Switzerland require their members to complete significant numbers of hours of CME in Anthroposophic Medicine. 

The required hours for annual CME in AM are 50 (Hungary), 20-40 (Netherlands), 30 (Switzerland), 25 (Germany).

AM is an official part of the Continuing Education Programme (CEP) for doctors in Germany, Romania and Sweden.
  
 
Anthroposophic medicinal products (AMP)
 
AMPs are on the market in certain EU member states under registration procedures that predate EU framework legislation for medicinal products for human use. The EU Community Code relating to medicinal products for human use does not recognise AMP, whereas it does, for example, recognise homeopathic MP via special simplified registration procedures. This has far-reaching consequences for marketing authorisation and registration of AMP within the European Community. Only one third of AMPs – those manufactured in accordance with homeopathic pharmacopoeias - and another third of AMPs – those which meet the criteria for traditional medicinal herbal products (restricted however to oral or external use without indication) - can be registered under simplified registration procedures. Under procedures of the Community code relating to medicinal products for human use, over 40 percent of AMP - encompassing the majority of AMP prescribed by doctors, with indications, and administered other than orally or externally - require market authorisation similar to that for conventional pharmaceutical products. These procedures, however, do not take account of the special features and manufacturing methods of AMP, and are therefore not appropriate.
 
 
Healthcare insurance
 
In Finland, France, Germany, Netherlands and Sweden fees for consultation with an AM physician are reimbursed by the national healthcare insurance system. In Austria, Belgium, France, Italy, Netherlands and Switzerland they are covered only by additional private insurance companies, with only partial coverage.
Costs for anthroposophic medicines are covered by the national healthcare insurance system in France, Germany and Sweden and the UK, and by additional private insurance companies in Austria, Belgium, Denmark, France, Germany, Italy, Netherlands and Switzerland.
 
There is only partial coverage, or up to a certain maximum, in Belgium, Denmark, France and Netherlands.
Current issues in Anthroposophic Medicine
©  IVAA 2010 
Last update: 21.8.2010
RESEARCH in AM
TRAINING in AM (in German)
REFERENCES:
Reviews












Anthroposophic Medicine: Effectiveness, Utility, Costs, Safety
read more...
Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients: A Systematic Review of Controlled Clinical Studies. Kienle GS and Kiene H. Integrative Cancer Therapies 2010:1-16. read more...
Clinical research in anthroposophic medicine. Hamre HJ, Kiene H, Kienle GS. Altern Ther Health Med 2009;15(6):52-55. read more... 
Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research. Kienle GS, Glockmann A, Schink M and Kiene H: Journal of Experimental & Clinical Cancer Research 2009;28:79. read more...
Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review. Ostermann T, Raak C, Büssing A BMC Cancer 2009, 9:451 (pp. 1-9) (http://www.biomedcentral.com/1471-2407/9/451) read more...
Comment on Mistletoe therapy in oncology (Cochrane Review 2008) IFAEMM: Kiene, Kienle 2008
read more...
IVAA and CAM – joint publications
Complementary Medicine (CAM) Its current position and its potential for European Healthcare 
Joint publication by ECH, ECPM, ICMART and IVAA, representing 132 medical CAM associations across Europe (March 2008)
read more... full text
Complementary Medicine (CAM) Its current position and its potential for European Healthcare (2008): Basic information, data, references, studies...
read more...
Promoting health and fighting illness as major political challenges in the EU read more...
Consensus Document "Non Conventional Medicine" read more...
Recent study-results
Predictors of outcome after 6 and 12 months following anthroposophic therapy for adult outpatients with chronic disease: a secondary analysis from a prospective observational study. Hamre HJ, Witt CM, Kienle GS, Glockmann A, Willich SN, Kiene H. BMC Research Notes 2010 Aug 3;3(218). read more...
Pharmacotherapy of elderly patients in everyday anthroposophic medical practice: a prospective, multicenter observational study. Jeschke E, Ostermann T, Vollmar HC, Tabali M, Kröz M, Bockelbrink A, Witt CM, Willich SN, Matthes H. BMC Geriatrics 2010, 10:48 read more...
Professional treatment in the context of medical pluralism - A German perspective. Kiene H, Brinkhaus B, Fischer G, Girke M, Hahn EG, Hoppe HD, Jütte R, Kraft K, Klitzsch W, Matthiessen PF, Meister P, Michalsen A, Teut M, Willich SN, Heimpel H. Europaen Journal of Integrative Medicine 2010;2:53-56 .... read more
A pilot study on the effects of a team building process on the perception of work environment in an integrative hospital for neurological rehabilitation. Ostermann T, Bertram M, Büssing A. BMC Complementary and Alternative Medicine 2010; 10, 10 (http://www.biomedcentral.com/1472-6882/10/10: 25-44) (pp. 1-10) read more...
God Image and Happiness in Chronic Pain Patients: The Mediating Role of Disease Interpretation.  Dezutter J, Luyckx K, Schaap-Jonker H, Büssing A, Hutsebaut D. Pain Medicine 2010, Mar 26. [Epub ahead of print] read more...
The treatment of children with anthroposophic medicine in daily primary care - Results of a network study. Jeschke E, Ostermann T, Tabali M, Bockelbrink A, Witt C, Willich S, Matthes H. European Journal of Integrative Medicine 2009;1(4):203. read more...
An integrtive approach of cancer treatment with mistletoe therapy, surgery, irradiation and chemotherapy in CAM settings. Schad F, Merkle A, Hoffmann G, Lenneweit G, Spahn G, Hesse M, Paxino C, Wellmann G, Matthes B, Baute R, Breitkreuz T, Matthes H. European Journal of Integrative Medicine 2009;1(4):184. read more...
Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings. Hamre HJ, Witt CM, Glockmann A, Ziegler R, Kienle GS, Willich SN, Kiene H.Eur J Health Econ 2009;DOI 10.1007/s10198-009-0203-0. read more...
More recent studies and results of working groups read more... 
Further studies with significance for Anthroposophic Medicine
Studies 2005-2010 and results of working groups (overview) read more... PDF
Allergic disease and sensitization in Steiner school children. Floistrup H, et al. The Parsifal Study Group. J Allergy Clin Immunol. 2006 Jan;117(1):59-66. Epub 2005 Nov 28. read more...(Abstract) PDF 
Anthroposophic vs. conventional therapy of acute respiratory and ear infections: a prospective outcomes study. Hamre HJ, Fischer M, Heger M, Riley D, Haidvogl M, Baars E, Bristol E, Evans M, Schwarz R, Kiene H. Wien Klin Wochenschr. 2005 Apr;117(7-8):256-68. read more...
Anthroposophic therapies in chronic disease: the Anthroposophic Medicine Outcomes Study (AMOS) Hamre HJ, Becker-Witt C, Glockmann A, Ziegler R, Willich SN, Kiene H. Eur J Med Res. 2004 Jul 30;9(7):351-60. read more... 
Evaluation of quality of life/life satisfaction in women with breast cancer in complementary and conventional care. Carlsson M, Arman M, Backman M, Flatters U, Hatschek T, Hamrin E. Acta Oncol. 2004;43(1):27-34. read more... PDF 
An anthroposophic lifestyle and intestinal microflora in infancy. Alm JS, Swartz J, Bjorksten B, Engstrand L, Engstrom J, Kuhn I, Lilja G, Mollby R, Norin E, Pershagen G, Reinders C, Wreiber K, Scheynius A. Pediatr Allergy Immunol. 2002 Dec;13(6):402-11.
(Abstract PDF)
Atopy in children of families with an anthroposophic lifestyle. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Lancet. 1999 May 1;353(9163):1485-8. (1999)
(Abstract PDF)